EXAS

Exact Sciences
EXAS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$10.12B
EV
$11.87B
Shares Outstanding
188.64M
Beta
0.96

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$68.46
P/E 2025E
259.71x
P/Revenue 2025E
3.27x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Exact Sciences Corporation

gainify
EXAS

Exact Sciences Corporation

EXAS

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal c...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Conroy, Kevin

Employees

6,950

IPO Date

2001-02-01

Headquarters

5505 Endeavor Lane, Madison, Wisconsin, 53719, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.